MoonLake Immunotherapeutics reported total assets of $573.95M and total liabilities of $145.75M for the quarter ended Jun 2026, up 24.7% year over year. This balance sheet covers 23 quarters of results from Dec 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||
| Current Assets | |||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 1.03M | 8.04M | 0.02M | 41.20M | 39.51M | 50.13M | 501.79M | 318.17M | 451.17M | 458.44M | 342.79M | 375.66M | 180.43M | 271.57M | 306.68M | 350.74M | 334.52M | 298.49M | 477.90M | ||||
| Short-term InvestmentsInvestments (Current) | 101.00M | 42.30M | 32.61M | 12.92M | 177.81M | 59.84M | 88.61M | 177.01M | 118.27M | 267.60M | 208.56M | 118.40M | 29.74M | 59.45M | 59.43M | 59.12M | |||||||
| Cash & Current Investments | 1.03M | 8.04M | 101.02M | 83.50M | 72.11M | 63.05M | 501.79M | 495.98M | 511.01M | 547.05M | 519.80M | 493.92M | 448.03M | 480.13M | 425.08M | 380.48M | 393.97M | 357.92M | 537.03M | ||||
| Receivables - OtherOther Receivables | 0.06M | 0.15M | 0.43M | 0.56M | 0.60M | -0.38M | 0.38M | 0.62M | 0.72M | 0.34M | 1.50M | 1.68M | 2.41M | 0.44M | 2.99M | 3.41M | 4.02M | 0.85M | 5.76M | 6.56M | |||
| Prepaid Assets | 0.18M | 1.45M | 0.14M | 5.11M | 4.48M | 4.18M | 3.08M | 3.96M | 3.31M | 2.10M | 5.04M | 15.41M | 15.98M | 23.42M | 23.15M | 26.99M | 26.71M | 22.86M | 32.96M | 26.45M | |||
| Current Assets | 1.21M | 9.64M | 116.16M | 98.38M | 88.54M | 76.51M | 66.50M | 506.37M | 500.01M | 514.17M | 553.59M | 536.88M | 512.32M | 474.29M | 506.26M | 455.48M | 411.21M | 421.69M | 396.64M | 570.04M | |||
| Non-Current Assets | |||||||||||||||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 0.05M | 0.06M | 0.05M | 0.05M | 0.05M | 0.04M | 0.04M | 0.32M | 0.51M | 0.48M | 0.58M | 0.72M | 0.71M | 0.67M | 0.62M | 0.58M | 0.53M | 0.49M | |||||
| Long-Term Investments | 115.04M | 115.04M | 115.05M | ||||||||||||||||||||
| Intangibles | |||||||||||||||||||||||
| Goodwill & Intangibles | |||||||||||||||||||||||
| Other Non-Current Assets | 8.42M | 6.32M | 4.13M | 2.06M | 1.70M | 1.70M | 0.59M | 0.60M | 1.34M | 1.34M | |||||||||||||
| Non-Current Assets | 115.04M | 0.05M | 115.05M | 0.06M | 0.05M | 0.33M | 0.29M | 0.25M | 0.21M | 12.37M | 10.53M | 8.00M | 5.90M | 3.64M | 5.00M | 4.62M | 3.12M | 2.74M | 3.73M | 3.91M | |||
| Assets | 116.25M | 9.68M | 231.21M | 98.43M | 88.59M | 76.84M | 66.80M | 506.62M | 500.22M | 526.54M | 564.12M | 544.88M | 518.21M | 477.93M | 511.26M | 460.10M | 414.33M | 424.43M | 400.37M | 573.95M | |||
| Liabilities | |||||||||||||||||||||||
| Current Liabilities | |||||||||||||||||||||||
| Accounts Payables | 1.57M | 0.79M | 1.06M | 0.25M | 3.83M | 4.36M | 3.40M | 1.84M | 3.48M | 5.14M | 10.71M | 8.99M | 12.01M | 17.08M | 25.28M | 29.55M | 23.38M | 17.04M | |||||
| Notes Payables | 15.00M | 0.15M | |||||||||||||||||||||
| Payables | 16.57M | 0.15M | 0.79M | 1.06M | 0.25M | 3.83M | 4.36M | 3.40M | 1.84M | 3.48M | 5.14M | 10.71M | 8.99M | 12.01M | 17.08M | 25.28M | 29.55M | 23.38M | 17.04M | ||||
| Accumulated Expenses | 2.06M | 4.52M | 5.80M | 3.07M | 4.96M | 7.26M | 3.30M | 2.62M | 6.75M | 6.93M | 4.12M | 5.82M | 7.93M | 12.10M | 10.54M | 8.73M | 21.59M | 14.69M | 21.81M | 27.11M | |||
| Short term Debt | 15.00M | ||||||||||||||||||||||
| Current Leases | 0.15M | 0.16M | 0.16M | 0.16M | 1.20M | 1.30M | 1.32M | 1.44M | 1.37M | 1.43M | 1.55M | 1.50M | 1.23M | 0.92M | 1.25M | ||||||||
| Total Current Liabilities | 2.06M | 21.09M | 202.79M | 3.86M | 6.02M | 7.67M | 7.28M | 7.13M | 10.31M | 9.97M | 8.91M | 12.28M | 20.08M | 22.46M | 23.98M | 27.36M | 48.37M | 45.48M | 46.11M | 45.39M | |||
| Non-Current Liabilities | |||||||||||||||||||||||
| Non-Current Debt | 73.02M | 73.40M | 73.74M | 74.10M | 99.02M | 99.51M | |||||||||||||||||
| Non-Current Deffered Revenue | 4.03M | 4.03M | 4.03M | ||||||||||||||||||||
| Pension | 1.32M | 0.02M | 0.00M | 1.32M | 0.31M | 0.32M | 0.26M | 2.49M | 0.46M | 0.54M | 0.69M | 0.62M | 0.54M | 0.57M | 0.55M | 0.35M | 0.07M | ||||||
| Preferred Stock Liabilities | 115.00M | 115.00M | |||||||||||||||||||||
| Minority Interest | 31.04M | 27.28M | 19.87M | 17.11M | 9.31M | 64.71M | 17.82M | 9.83M | 9.37M | 7.31M | 6.57M | 5.06M | 4.21M | 2.29M | |||||||||
| Operating Leases | 0.13M | 0.25M | 0.21M | 0.17M | 2.50M | 3.66M | 3.34M | 3.38M | 1.46M | 2.57M | 2.39M | 1.99M | 0.37M | 1.78M | 2.02M | ||||||||
| Total Non-Current Liabilities | 0.24M | 0.02M | 0.00M | 0.41M | 0.41M | 0.38M | 0.27M | 3.08M | 2.82M | 2.56M | 2.63M | 2.08M | 74.70M | 74.79M | 74.78M | 74.47M | 100.24M | 100.36M | |||||
| Total Liabilities | 6.08M | 21.33M | 206.82M | 3.88M | 6.02M | 8.08M | 7.68M | 7.51M | 10.58M | 13.05M | 11.73M | 14.85M | 22.71M | 24.54M | 98.68M | 102.15M | 123.14M | 119.95M | 146.35M | 145.75M | |||
| Shareholder's Equity | |||||||||||||||||||||||
| Total Debt | 30.00M | 0.15M | 73.02M | 73.40M | 73.74M | 74.10M | 99.02M | 99.51M | |||||||||||||||
| Common Equity | -3.10M | 13.12M | -25.27M | 500.00M | 82.57M | 68.77M | 500.00M | 500.00M | 489.64M | 513.49M | 552.39M | 530.03M | 495.50M | 453.39M | 500.00M | 500.00M | 291.19M | 304.48M | 254.02M | 428.19M | |||
| Liabilities and Shareholders Equity | 116.25M | 9.68M | 231.21M | 98.43M | 88.59M | 76.84M | 66.80M | 506.62M | 500.22M | 526.54M | 564.12M | 544.88M | 518.21M | 477.93M | 511.26M | 460.10M | 414.33M | 424.43M | 400.37M | 573.95M | |||
| Treasury Shares | 1.94M | 0.77M | |||||||||||||||||||||
| Retained Earnings | -4.84M | -53.64M | 34.16M | 122.05M | 123.83M | 129.19M | 131.31M | 589.55M | 531.27M | 609.97M | 670.19M | 672.00M | 675.34M | 677.41M | 680.66M | 683.96M | 689.11M | 766.78M | 786.31M | 1,021.98M | |||
| Preferred Shares | 0.07M | 22.88M |